Client News

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Syntekabio Introduces Develop Now, Pay Later with AI-powered STB LaunchPad Program

Advanced Medical Balloons Appoints Top-Performing US Life-Science Executive to Drive Business Growth

Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform

InflaRx Announces Participation in September Investor Events

Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency

Medigene AG Implements Announced 2:1 Share Capital Reduction and Consolidation of the Shares Effective August 29, 2024

Affluent Medical to attend German Fall Conference in Frankfurt in September 2024

Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update

Formycon reports a strong first half-year with multiple milestones achieved